Since COVID-19 surfaced, consumers have been bombarded with media coverage about the spread of the pandemic, most of which has been less than positive. Medicare beneficiaries are extremely vulnerable right now, and they need a voice of reason. As a health plan, you can be that voice.
With bid submissions on the horizon, CMS’ recently announced Advance Notice and Proposed Rule should be top of mind for product strategy leaders. Read our key takeaways.
CMS has published key information regarding 2021 MA Part C & D bids, payments and rules in a series of documents released 2/5/2020. Here’s what you should know.
CMS has proposed numerous changes to the Star Ratings program in Part 2 of the Advance Notice and the 2021 and 2022 MA and Part D Proposed Rule. Read the key takeaways.
The countdown for network development, expansion, and Health Service Delivery (HSD) submission for 2020 is upon us. It is imperative that network strategy planning starts now in order to avoid the pitfalls plans have faced in the past.
Plan should start to take steps now to determine the impact of the blend and model change in the 2021 Advance Notice to their risk scores and revenue, and mitigate potential adverse impacts of the risk adjustment changes.
The Office of Inspector General (OIG) report on the use of chart reviews in Medicare Advantage risk adjustment raises a number of concerns for Medicare Advantage Organizations (MAOs). How can plans mitigate risk from chart review submissions and stay compliant with CMS risk adjustment guidelines to ensure complete and accurate reimbursement?
